US Patent Tri­al and Ap­peal Board to re­con­sid­er Spruce patents around treat­ment for adren­al dis­or­der

The US Patent Tri­al and Ap­peal Board will take a clos­er look at two patents cov­er­ing Spruce Bio­sciences’ ex­per­i­men­tal treat­ment for an adren­al dis­or­der, re­vers­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER